P3 Health Partners: Alyeska reports 4.9% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
P3 Health Partners Inc. (PIII) reported that Alyeska Investment Group, L.P., Alyeska Fund GP, LLC and Anand Parekh each beneficially owned 191,686 Class A shares, or 4.90%, as of September 30, 2026. The position is held by Alyeska Master Fund, L.P.; Alyeska Investment Group exercises voting and investment control, while Parekh may be deemed a beneficial owner and disclaims ownership. The reporting persons hold warrants exercisable for 486,063 shares, but a 4.9% beneficial ownership limitation permits exercise of only 191,686 shares, based on 3,911,962 shares outstanding cited from the Form 10-Q dated August 10, 2026.
Key Figures
Key Terms
beneficial ownership limitation regulatory
Rule 13d-1(k) regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.